
PRLD
(NASDAQ)Prelude Therapeutics Incorporated
$2.11-- (--)
Loading... - Market loading
Prelude Therapeutics Incorporated (PRLD) Stock Analyst Forecast
Expert analyst consensus ratings, 12-month price targets, and professional investment recommendations.
No Analyst Ratings Available
There are currently no analyst ratings available for PRLD in the last 90 days.
Analyst ratings will appear here once they become available from our data sources.